The impact of the Covid-19 pandemic on R&D and commercialization of new drugs and vaccines
Intoccia, Andrea Erminio (A.A. 2019/2020) The impact of the Covid-19 pandemic on R&D and commercialization of new drugs and vaccines. Tesi di Laurea in Health care management, Luiss Guido Carli, relatore Daniele Mascia, pp. 150. [Master's Degree Thesis]
| ![[img]](http://tesi.luiss.it/style/images/fileicons/application_pdf.png) | PDF (Full text) Restricted to Registered users only Download (3MB) | Request a copy | 
Abstract/Index
From laboratory to patient: the journey of medicinal products. Product roadmap of medicines. Vaccine making: a complex pipeline. Making steps toward the future: how to cut decades of research and technology implementation thanks to new opportunities and challenges. Procedures questioned by the global health emergency due to the pandemic crisis: new models with high risks management are born. Impacts of Covid-19 on the pharmaceutical sector. Biopharmaceutical companies: the fight against the novel Coronavirus. Partnership and collaboration in response to Covid-19 pandemic. New strategies for biopharma: the next normal. Lesson learned from Covid-19 pandemic for a future based on innovation. Shaping the next normal.
References
Bibliografia: pp. 122-149.
| Thesis Type: | Master's Degree Thesis | 
|---|---|
| Institution: | Luiss Guido Carli | 
| Degree Program: | Master's Degree Programs > Master's Degree Program in Gestione d'impresa (LM-77) | 
| Chair: | Health care management | 
| Thesis Supervisor: | Mascia, Daniele | 
| Thesis Co-Supervisor: | Homberg, Fabian Kurt Falk | 
| Academic Year: | 2019/2020 | 
| Session: | Extraordinary | 
| Additional Information: | Sessione anticipata 2020/2021. | 
| Deposited by: | Alessandro Perfetti | 
| Date Deposited: | 14 Jun 2021 07:03 | 
| Last Modified: | 14 Jun 2021 07:03 | 
| URI: | https://tesi.luiss.it/id/eprint/29747 | 
Downloads
Downloads per month over past year
Repository Staff Only
|  | View Item | 


